Kura Oncology KURA
NASDAQ KURA
$10.63 -0.02 (-0.23%)
As of: Oct 2, 2026 · 3:18 PM EDT

Kura Oncology (KURA) Revenue (2025 - 2026)

Updated

Kura Oncology's Revenue came in at $20.87 million for Q2 2026, up 36.5% from $15.29 million a year earlier and up 14.3% from the prior quarter.

Analysis

Kura Oncology (KURA) Revenue (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kura Oncology reported Revenue of $77.23 million; for FY2025, it was $67.48 million, up 25.2% from FY2024.

  • Going back by year, Revenue was $53.88 million in FY2024.
  • Business Quant data shows KURA's Revenue at $18.27 million (Q1 2026), $17.34 million (Q4 2025) and $20.75 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Kura Oncology 952.70 Mn 952.70 Mn 20.63 Mn 20.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.87 Mn
Mar 31, 2026 18.27 Mn
Dec 31, 2025 17.34 Mn
Sep 30, 2025 20.75 Mn
Jun 30, 2025 15.29 Mn
Mar 31, 2025 14.11 Mn
API Access

Kura Oncology Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KURA&period=max&api_key=YOUR_API_KEY